122 related articles for article (PubMed ID: 8408733)
1. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
Bowles SK; Reeves RA; Cardozo L; Edwards DJ
J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
[TBL] [Abstract][Full Text] [Related]
2. Quinidine interaction with nifedipine and felodipine: pharmacokinetic and pharmacodynamic evaluation.
Bailey DG; Freeman DJ; Melendez LJ; Kreeft JH; Edgar B; Carruthers SG
Clin Pharmacol Ther; 1993 Mar; 53(3):354-9. PubMed ID: 8453855
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interactions of nifedipine and quinidine.
Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans.
Schellens JH; Ghabrial H; van der Wart HH; Bakker EN; Wilkinson GR; Breimer DD
Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):520-8. PubMed ID: 1934865
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
Bramer SL; Suri A
Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.
Laganière S; Davies RF; Carignan G; Foris K; Goernert L; Carrier K; Pereira C; McGilveray I
Clin Pharmacol Ther; 1996 Sep; 60(3):255-64. PubMed ID: 8841148
[TBL] [Abstract][Full Text] [Related]
7. Quinidine does not alter antipyrine metabolism.
Bowles SK; Cardozo L; Edwards DJ
J Clin Pharmacol; 1990 Mar; 30(3):267-71. PubMed ID: 2312782
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of the nifedipine-quinidine interaction.
Munger MA; Jarvis RC; Nair R; Kasmer RJ; Nara AR; Urbancic A; Green JA
Clin Pharmacol Ther; 1989 Apr; 45(4):411-6. PubMed ID: 2702799
[TBL] [Abstract][Full Text] [Related]
9. Effect of cimetidine or ranitidine administration on nifedipine pharmacokinetics and pharmacodynamics.
Schwartz JB; Upton RA; Lin ET; Williams RL; Benet LZ
Clin Pharmacol Ther; 1988 Jun; 43(6):673-80. PubMed ID: 3378388
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual variability in nifedipine pharmacokinetics and effects in healthy subjects.
Soons PA; Schoemaker HC; Cohen AF; Breimer DD
J Clin Pharmacol; 1992 Apr; 32(4):324-31. PubMed ID: 1569235
[TBL] [Abstract][Full Text] [Related]
11. A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol.
Fitzsimons TJ; Norris SC; Adam HK; Ryan J; McAinsh J
Biopharm Drug Dispos; 1991; 12(1):81-94. PubMed ID: 2039814
[TBL] [Abstract][Full Text] [Related]
12. Effects of diltiazem on the pharmacokinetics of nifedipine.
Ohashi K; Tateishi T; Sudo T; Sakamoto K; Toyosaki N; Hosoda S; Toyo-oka T; Sugimoto K; Kumagai Y; Ebihara A
J Cardiovasc Pharmacol; 1990 Jan; 15(1):96-101. PubMed ID: 1688989
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
Vozeh S; Uematsu T; Guentert TW; Ha HR; Follath F
Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.
Edeki TI; He H; Wood AJ
JAMA; 1995 Nov 22-29; 274(20):1611-3. PubMed ID: 7474246
[TBL] [Abstract][Full Text] [Related]
16. Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation.
Zhou HH; Anthony LB; Roden DM; Wood AJ
Clin Pharmacol Ther; 1990 Jun; 47(6):686-93. PubMed ID: 2357863
[TBL] [Abstract][Full Text] [Related]
17. Lisinopril and nifedipine: no acute interaction in normotensives.
Lees KR; Reid JL
Br J Clin Pharmacol; 1988 Mar; 25(3):307-13. PubMed ID: 2833920
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole increases plasma concentrations of quinidine.
Kaukonen KM; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
[TBL] [Abstract][Full Text] [Related]
20. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
